Quantitative DNA methylation analysis of candidate genes in cervical cancer

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Siegel, Erin M ^a   Riggs, Bridget M ^a   Delmas, Amber L ^b   Koch, Abby ^a   Hakam, Ardeshir ^a   Brown, Kevin D ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; FRAGILE HISTIDINE TRIAD PROTEIN; GENOMIC DNA; RETINOIC ACID RECEPTOR BETA; SLIT2 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ADULT; AGE; APC GENE; AREA UNDER THE CURVE; ARTICLE; CARCINOGENESIS; CASE CONTROL STUDY; CCNA GENE; CDH1 GENE; CDH13 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DAPK1 GENE; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; DNA METHYLATION; DNA METHYLATION INDEX; EPIGENETICS; FEMALE; FHIT GENE; GENE AND NUCLEIC ACID PARAMETERS; HUMAN; HUMAN CELL; HUMAN TISSUE; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RARB GENE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SLIT2 GENE; TIMP3 GENE; TUMOR GENE; UTERINE CERVIX CARCINOMA; WIF1 GENE; GENETICS; SQUAMOUS CELL CARCINOMA; SURVIVAL ANALYSIS; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84926317008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122495     Document Type: Article

References (56)

1. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692. PMID: 17320506
2. Wentzensen N, Sherman ME, Schiffman M, Wang SS (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112: 293-299. doi: 10.1016/j.ygyno.2008.10.012 PMID: 19054549
3. Whiteside MA, Siegel EM, Unger ER (2008) Human papillomavirus and molecular considerations for cancer risk. Cancer 113: 2981-2994. doi: 10.1002/cncr.23750 PMID: 18980282
4. Lorincz AT (2011) The Promise and the Problems of Epigenetics Biomarkers in Cancer. Expert opinion on medical diagnostics 5: 375-379. PMID: 22003365
5. van der Meide WF, Snellenberg S, Meijer CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, et al. (2011) Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. Gynecol Oncol 123: 116-122. doi: 10.1016/j.ygyno.2011.06.015 PMID: 21726894
6. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, et al. (2007) Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 107: 549-553. PMID: 17894941
7. Jo H, Kang S, Kim JW, Kang GH, Park NH, Song YS, et al. (2007) Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer. The journal of obstetrics and gynaecology research 33: 236-241. PMID: 17578348
8. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C (2010) Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 116: 99-104. doi: 10.1016/j.ygyno.2009.09.032 PMID: 19836067
9. Yang N, Nijhuis ER, Volders HH, Eijsink JJ, Lendvai A, Zhang B, et al. (2010) Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol 32: 131-143. doi: 10.3233/CLO-2009-0510 PMID: 20208141
10. Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, et al. (2004) Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 10: 3396-3400. PMID: 15161694
11. Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, et al. (2009) Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 18: 3000-3007. doi: 10.1158/1055-9965.EPI-09-0405 PMID: 19843677
12. Sahasrabuddhe VV, Luhn P, Wentzensen N (2011) Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future microbiology 6: 1083-1098. doi: 10.2217/fmb.11.87 PMID: 21958146
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826. PMID: 8790415
14. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150. PMID: 12866414
15. Tost J, Dunker J, Gut IG (2003) Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 35: 152-156. PMID: 12866415
16. Vasiljevic N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT (2014) Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol 132: 709-714. doi: 10.1016/j.ygyno.2014.02.001 PMID: 24508839
17. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. (2009) A review of human carcinogens - Part B: biological agents. Lancet Oncol 10: 321-322. PMID: 19350698
18. Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD, Brown KD (2009) Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer 48: 83-97. doi: 10.1002/gcc.20620 PMID: 18836996
19. Janes H, Longton G, Pepe MS (2009) Accomodating covariates in receiver operating charateristic analysis. The Stata Journal 9: 17-39. PMID: 20046933
20. Pepe MS, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. The Stata Journal 9: 1-16. PMID: 20161343
21. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature reviews Genetics 13: 484-492. doi: 10.1038/nrg3230 PMID: 22641018
22. Murphy SK, Huang Z, Hoyo C (2012) Differentially methylated regions of imprinted genes in prenatal, perinatal and postnatal human tissues. PLoS One 7: e40924. doi: 10.1371/journal.pone.0040924 PMID: 22808284
23. Reed K, Poulin ML, Yan L, Parissenti AM (2010) Comparison of bisulfite sequencing PCR with pyrosequencing for measuring differences in DNA methylation. Anal Biochem 397: 96-106. doi: 10.1016/j.ab.2009.10.021 PMID: 19835834
24. Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, Schramm J, et al. (2007) Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 9: 368-381. PMID: 17591937
25. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, et al. (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. International journal of cancer 119: 1908-1914. PMID: 16736496
26. Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, et al. (2004) Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2: 289-295. PMID: 15192122
27. Choi CH, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, et al. (2007) Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett 255: 26-33. PMID: 17467893
28. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, et al. (2003) Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome. Mol Cancer 2: 24. PMID: 12773202
29. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, Dem A, et al. (2005) Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 97: 273-282. PMID: 15713962
30. Iliopoulos D, Oikonomou P, Messinis I, Tsezou A (2009) Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Oncol Rep 22: 199-204. PMID: 19513524
31. Mitra S, Mazumder-Indra D, Mondal RK, Basu PS, Roy A, Roychoudhury S, et al. (2012) Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances. PLoS One 7: e38342. doi: 10.1371/journal.pone.0038342 PMID: 22719878
32. Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, Durst M, et al. (2006) Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 5: 16. PMID: 16700909
33. Cohen O, Feinstein E, Kimchi A (1997) DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. The EMBO journal 16: 998-1008. PMID: 9118961
34. Wang WJ, Kuo JC, Yao CC, Chen RH (2002) DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. The Journal of cell biology 159: 169-179. PMID: 12370243
35. Hernandez JM, Siegel EM, Riggs B, Eschrich S, Elahi A, Qu X, et al. (2012) DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia. PLoS One 7: e50533. doi: 10.1371/journal.pone.0050533 PMID: 23226306
36. Agarwal C, Rorke EA, Irwin JC, Eckert RL (1991) Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation. Cancer Res 51: 3982-3989. PMID: 1713124
37. Benbrook DM, Lu S, Flanagan C, Shen-Gunther J, Angros LH, Lightfoot SA (1997) Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells. Gynecol Oncol 66: 114-121. PMID: 9234931
38. Geisen C, Denk C, Gremm B, Baust C, Karger A, Bollag W, et al. (1997) High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells. Cancer Res 57: 1460-1467. PMID: 9108446
39. Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, et al. (2006) Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer 16: 1234-1240. PMID: 16803511
40. Widschwendter A, Ivarsson L, Blassnig A, Muller HM, Fiegl H, Wiedemair A, et al. (2004) CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer 109: 163-166. PMID: 14750164
41. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF (2001) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7: 584-589. PMID: 11297252
42. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, et al. (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119: 1908-1914. PMID: 16736496
43. Dong SM, Kim HS, Rha SH, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7: 1982-1986. PMID: 11448914
44. Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, et al. (2009) Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol 112: 301-306. doi: 10.1016/j.ygyno.2008.10.004 PMID: 19038436
45. Delmas AL, Riggs BM, Pardo CE, Dyer LM, Darst RP, Izumchenko EG, et al. (2011) WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix. Carcinogenesis 32: 1625-1633. doi: 10.1093/carcin/bgr193 PMID: 21873353
46. Prasad A, Paruchuri V, Preet A, Latif F, Ganju RK (2008) Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells. The Journal of biological chemistry 283: 26624-26633. doi: 10.1074/jbc.M800679200 PMID: 18611862
47. Nones K, Waddell N, Song S, Patch AM, Miller D, Johns A, et al. (2014) Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. International journal of cancer Journal international du cancer 135: 1110-1118. doi: 10.1002/ijc.28765 PMID: 24500968
48. Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F (2003) Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22: 4611-4616. PMID: 12881718
49. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, et al. (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431-436. PMID: 10201374
50. Laurson J, Khan S, Chung R, Cross K, Raj K (2010) Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis 31: 918-926. doi: 10.1093/carcin/bgq027 PMID: 20123756
51. Lin TS, Lee H, Chen RA, Ho ML, Lin CY, Chen YH, et al. (2005) An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection. Cancer Lett 226: 77-84. PMID: 16004934
52. Burgers WA, Blanchon L, Pradhan S, de Launoit Y, Kouzarides T, Fuks F (2007) Viral oncoproteins target the DNA methyltransferases. Oncogene 26: 1650-1655. PMID: 16983344
53. Leonard SM, Wei W, Collins SI, Pereira M, Diyaf A, Constandinou-Williams C, et al. (2012) Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women. Carcinogenesis 33: 1286-1293. doi: 10.1093/carcin/bgs157 PMID: 22552403
54. Hesselink AT, Heideman DA, Steenbergen RD, Coupe VM, Overmeer RM, Rijkaart D, et al. (2011) Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 17: 2459-2465. doi: 10.1158/1078-0432.CCR-10-2548 PMID: 21389098
55. Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, et al. (2014) Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis 209: 1739-1743. doi: 10.1093/infdis/jit799 PMID: 24319284
56. Chaopatchayakul P, Jearanaikoon P, Yuenyao P, Limpaiboon T (2010) Aberrant DNA methylation of apoptotic signaling genes in patients responsive and nonresponsive to therapy for cervical carcinoma. Am J Obstet Gynecol 202: 281 e281-289. doi: 10.1016/j.ajog.2009.11.037 PMID: 20117760